QT
ENZ

Quantamental Technologies’s Enzo Biochem, Inc. ENZ Stock Holding History

Quantamental Technologies’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,699
Closed -$6K – 1396
2019
Q3 		$6K Hold
1,699
– – ﹤0.01% 1377
2019
Q2 		$6K Hold
1,699
– – ﹤0.01% 1319
2019
Q1 		$5K Sell
1,699
-200
-11% -$655 ﹤0.01% 1332
2018
Q4 		$5K Buy
+1,899
New +$6.22K ﹤0.01% 1227

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Quantamental Technologies's ENZ Position: Q4 2019 in Review

Quantamental Technologies sold out of Enzo Biochem, Inc. (ENZ) in Q4 2019, closing a stake of 1,699 shares — an estimated $6K sold.

Quantamental Technologies first reported a position in ENZ in Q4 2018 and held it in 4 quarters. The position peaked at $6K in Q3 2019. 81 funds tracked by Wall St. Rank hold ENZ as of Q4 2019.

  • Quantamental Technologies reported no remaining Enzo Biochem, Inc. position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 1,699 Enzo Biochem, Inc. shares in Q4 2019, an estimated $6K.
  • Quantamental Technologies first reported a position in Enzo Biochem, Inc. in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Enzo Biochem, Inc. position peaked at $6K in Q3 2019.
  • 81 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.